FDA adcomm turns down FibroGen, AZ’s roxadustat for CKD anaemiaSafety concerns seem to have scuppered any hope of a near-term approval for FibroGen and AstraZeneca’s roxadustat for Share XFDA adcomm turns down FibroGen, AZ’s roxadustat for CKD anaemiahttps://pharmaphorum.com/news/fda-adcomm-turns-down-fibrogen-azs-roxadustat-for-ckd-anaemia/
Astellas gets nod in Japan for roxadustat, ahead of GSK rivalAstellas has its first approval for roxadustat, getting a green light in Japan for the drug as a Share XAstellas gets nod in Japan for roxadustat, ahead of GSK rivalhttps://pharmaphorum.com/news/astellas-gets-nod-in-japan-for-roxadustat-ahead-of-gsk-rival/
